Literature DB >> 2781040

Event-related brain potentials in depressed patients treated with electroconvulsive therapy.

J A Coffman1, M W Torello, C E Lewis, L D Fortin, D J Martin.   

Abstract

1. As impairment of attention has long been recognized as a clinical feature of depression, we undertook to evaluate in depressed subjects and controls a feature of the event-related brain potentials (ERP) the N100 wave which has been linked to attentional processes. 2. This study involved collection of EEG data in an "auditory oddball" ERP paradigm in 9 depressed subjects prior to and following a course of 6 electroconvulsive therapy (ECT) treatments, as well as 11 controls. Concurrent Hamilton depression rating scales provided a measure of symptomatic severity. 3. Pretreatment N100 amplitude was significantly lower in the depressed group while N100 latency was greater than among controls, with treatment differences from control values disappeared. Further a robust correlation (r = 0.85 p less than or equal to .0038) emerged between N100 amplitude (increased amplitude being lower) and severity of depression. 4. Those results provide evidence for a physiological attentional disturbance in depression and suggest that certain features of this disturbance relate directly to symptom severity.

Entities:  

Mesh:

Year:  1989        PMID: 2781040     DOI: 10.1016/0278-5846(89)90056-0

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  2 in total

1.  Rectal tone and brain information processing in irritable bowel syndrome.

Authors:  S Blomhoff; S Spetalen; M B Jacobsen; M Vatn; U F Malt
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

2.  An Eye Tracking and Event-Related Potentials Study With Visual Stimuli for Adolescents Emotional Issues.

Authors:  Quan Wang; Xiaojie Wei; Ruochen Dang; Feiyu Zhu; Shaokang Yin; Bingliang Hu
Journal:  Front Psychiatry       Date:  2022-06-30       Impact factor: 5.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.